Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Single-Dose Intranasal Administration of AdCOVID Elicits Systemic and Mucosal Immunity against SARS-CoV-2 and Fully Protects Mice from Lethal Challenge
R. Glenn King, Aarón Silva-Sánchez, Jessica N. Peel, et al.
Vaccines (2021) Vol. 9, Iss. 8, pp. 881-881
Open Access | Times Cited: 109

Showing 1-25 of 109 citing articles:

Adenoviral vector vaccine platforms in the SARS-CoV-2 pandemic
Samir Andrade Mendonça, Réka Lőrincz, Paul Boucher, et al.
npj Vaccines (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 243
Intranasal COVID-19 vaccines: From bench to bed
Aqu Alu, Li Chen, Lei Hong, et al.
EBioMedicine (2022) Vol. 76, pp. 103841-103841
Open Access | Times Cited: 210
Intranasal vaccines for SARS-CoV-2: From challenges to potential in COVID-19 management
Vivek P. Chavda, Lalitkumar K. Vora, Anjali Pandya, et al.
Drug Discovery Today (2021) Vol. 26, Iss. 11, pp. 2619-2636
Open Access | Times Cited: 188
Exosomes decorated with a recombinant SARS-CoV-2 receptor-binding domain as an inhalable COVID-19 vaccine
Zhenzhen Wang, Kristen D. Popowski, Dashuai Zhu, et al.
Nature Biomedical Engineering (2022) Vol. 6, Iss. 7, pp. 791-805
Open Access | Times Cited: 181
Rethinking next-generation vaccines for coronaviruses, influenzaviruses, and other respiratory viruses
David M. Morens, Jeffery K. Taubenberger, Anthony S. Fauci
Cell Host & Microbe (2023) Vol. 31, Iss. 1, pp. 146-157
Open Access | Times Cited: 126
A live attenuated virus-based intranasal COVID-19 vaccine provides rapid, prolonged, and broad protection against SARS-CoV-2
Junyu Chen, Pui Wang, Lunzhi Yuan, et al.
Science Bulletin (2022) Vol. 67, Iss. 13, pp. 1372-1387
Open Access | Times Cited: 100
Adenovirus type 5 SARS-CoV-2 vaccines delivered orally or intranasally reduced disease severity and transmission in a hamster model
Stephanie N. Langel, Susan Johnson, C Martínez, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 658
Open Access | Times Cited: 91
Adaptive Immune Responses and Immunity to SARS-CoV-2
Dragan Primorac, Kristijan Vrdoljak, Petar Brlek, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 90
Mucosal Vaccines, Sterilizing Immunity, and the Future of SARS-CoV-2 Virulence
Daniele Focosi, Fabrizio Maggi, Arturo Casadevall
Viruses (2022) Vol. 14, Iss. 2, pp. 187-187
Open Access | Times Cited: 87
Viral vectored vaccines: design, development, preventive and therapeutic applications in human diseases
Shen Wang, Bo Liang, Weiqi Wang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 87
Mucosal immunity: The missing link in comprehending SARS-CoV-2 infection and transmission
Michael W. Russell, Jiří Městecký
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 77
COVID-19 intranasal vaccines: current progress, advantages, prospects, and challenges
Kuldeep Dhama, Manish Dhawan, Ruchi Tiwari, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 5
Open Access | Times Cited: 75
Mucosal vaccines for SARS-CoV-2: scientific gaps and opportunities—workshop report
Jane M. Knisely, Lucas E. Buyon, Rebecca Mandt, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 68
Adenoviral Vector-Based Vaccine Platform for COVID-19: Current Status
Vivek P. Chavda, Rajashri Bezbaruah, Disha Valu, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 432-432
Open Access | Times Cited: 49
Combinatorial development of nebulized mRNA delivery formulations for the lungs
Allen Yujie Jiang, Jacob Witten, Idris O. Raji, et al.
Nature Nanotechnology (2023) Vol. 19, Iss. 3, pp. 364-375
Open Access | Times Cited: 47
Viral Vectors for COVID-19 Vaccine Development
Kenneth Lundström
Viruses (2021) Vol. 13, Iss. 2, pp. 317-317
Open Access | Times Cited: 85
Status Report on COVID-19 Vaccines Development
Arun Kumar, William E. Dowling, Raúl Gómez Román, et al.
Current Infectious Disease Reports (2021) Vol. 23, Iss. 6
Open Access | Times Cited: 78
Gold-Nanostar-Chitosan-Mediated Delivery of SARS-CoV-2 DNA Vaccine for Respiratory Mucosal Immunization: Development and Proof-of-Principle
Uday Kumar Sukumar, Rayhaneh Afjei, Katherine W. Ferrara, et al.
ACS Nano (2021) Vol. 15, Iss. 11, pp. 17582-17601
Open Access | Times Cited: 70
Inhalation Delivery for the Treatment and Prevention of COVID-19 Infection
Basanth Babu Eedara, Wafaa Alabsi, David Encinas-Basurto, et al.
Pharmaceutics (2021) Vol. 13, Iss. 7, pp. 1077-1077
Open Access | Times Cited: 56
Recent review of COVID-19 management: diagnosis, treatment and vaccination
Vivek P. Chavda, Suneetha Vuppu, Toshika Mishra, et al.
Pharmacological Reports (2022) Vol. 74, Iss. 6, pp. 1120-1148
Open Access | Times Cited: 55
Intranasal administration of BReC-CoV-2 COVID-19 vaccine protects K18-hACE2 mice against lethal SARS-CoV-2 challenge
Ting Y. Wong, Katherine S. Lee, Brynnan P. Russ, et al.
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 43
Nasal sprays for treating COVID-19: a scientific note
Vivek P. Chavda, Kajal Baviskar, Dixa A. Vaghela, et al.
Pharmacological Reports (2023) Vol. 75, Iss. 2, pp. 249-265
Open Access | Times Cited: 26
Same yet different — how lymph node heterogeneity affects immune responses
Paulina Cruz de Casas, Konrad Knöpper, Rupak Dey Sarkar, et al.
Nature reviews. Immunology (2023) Vol. 24, Iss. 5, pp. 358-374
Closed Access | Times Cited: 24
Mucosal vaccine-induced cross-reactive CD8+ T cells protect against SARS-CoV-2 XBB.1.5 respiratory tract infection
Baoling Ying, Tamarand L. Darling, Pritesh Desai, et al.
Nature Immunology (2024) Vol. 25, Iss. 3, pp. 537-551
Open Access | Times Cited: 12
Application of Viral Vectors for Vaccine Development with a Special Emphasis on COVID-19
Kenneth Lundström
Viruses (2020) Vol. 12, Iss. 11, pp. 1324-1324
Open Access | Times Cited: 50
Page 1 - Next Page

Scroll to top